Dr. Judd Moul, professor of surgery and director of the Duke Prostate Center, was quoted in a recent NYTimes article. For the first time, two independent clinical trials have showed that two different drugs give certain patients about two more years before their cancer metastasizes. “‘We’re going from rags to riches,'” says Dr. Moul. Read the full article here.
NYTimes: “Two Prostate Cancer Drugs Delay Spread of the Disease by Two Years”
Search Posts
YOU MAY ALSO LIKE
Related Posts
The benefits landscape is shifting fast — and Benefits Consultants are at the center of it. Employers are facing more...
In honor of Breast Cancer Awareness Month, the Summus team had the privilege of hearing from Dr. Chasse Bailey-Dorton, a...
As employers complete 2026 benefits planning, one thing is clear: this was one of the most difficult renewal seasons in...
Employee benefits leaders face unprecedented pressure to deliver meaningful healthcare support, all while navigating rising costs, reducing complexity, and proving...